Effect of Intranasal Mupirocin Prophylaxis on Methicillin-Resistant Staphylococcus aureus Transmission and Invasive Staphylococcal Infections in a Neonatal Intensive Care Unit. (2nd April 2018)

• Record Type: Journal Article
• Authors: Ristagno, Elizabeth H.; Bryant, Kristina A.; Boland, Lynette F.; Stout, Gordon G.; Junkins, Alan D.; Woods, Charles R.; Myers, John A.; Espinosa, Claudia M.
• Is Part Of: Infection control and hospital epidemiology. Volume 39:Number 6(2018)
• Page Start: 741
• Page End: 745
• Publication Date: 2018-04-02
• Subjects: Nosocomial infections -- Epidemiology -- Periodicals; Health facilities -- Sanitation -- Periodicals; Hospital buildings -- Sanitation -- Periodicals; Cross Infection -- Periodicals; Epidemiology -- Periodicals; Hospitals -- Periodicals; Infection Control -- Periodicals; 614.44
• DOI: 10.1017/ice.2018.44
• Languages: English
• ISSNs: 0899-823X

Abstract

Abstract : The use of monthly intranasal mupirocin was associated with a significant reduction in the rate of methicillin-resistant Staphylococcus aureus transmission and Staphylococcus aureus invasive infection in a large neonatal intensive care unit. Resistance to mupirocin emerged over time, but it was rare and was not associated with adverse clinical outcomes. Infect Control Hosp Epidemiol 2018;39:741–745